Results 91 to 100 of about 517 (142)

Brusatol inhibits metastasis of triple-negative breast cancer through metabolic reprogramming

open access: yesFrontiers in Oncology
BackgroundTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) characterized by a high risk of metastasis and poor prognosis. Current chemotherapy-based treatments are often limited by systemic toxicity and drug resistance.
Xuan Yu   +12 more
doaj   +1 more source

Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer via Nrf2-Mediated Stress-Defense Pathway Suppression and Ferroptosis Induction

open access: yes
In situ oxygen generation is the most common strategy to boost reactive oxygen species (ROS) for enhancing the efficacy of phototherapy in cancer, including photodynamic therapy (PDT) and photothermal therapy (PTT).
Xiaolan Cheng (8669931)   +11 more
core   +1 more source

The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation [PDF]

open access: yes
Survival rates for those with metastatic osteosarcoma (OS) have not improved over the last four decades. It is imperative that novel approaches to treating and curing OS be sought.
Emily Stephens   +5 more
core   +1 more source

Brusatol enhances the chemotherapy efficacy of Cisplatin and Gemcitabine in KKU-100 cholangiocarcinoma cells through ROS-mediated apoptosis

open access: yesScientific Reports
One of the main obstacles in Cholangiocarcinoma (CCA) treatment is drug resistant to the standard therapy, Cisplatin combined with Gemcitabine (Cis/Gem).
Tueanjai Khunluck   +5 more
doaj   +1 more source

Vanillylacetone attenuates cadmium chloride-induced hippocampal damage and memory loss through up-regulation of nuclear factor erythroid 2-related factor 2 gene and protein expression

open access: yesNeural Regeneration Research
Memory loss and dementia are major public health concerns with a substantial economic burden. Oxidative stress has been shown to play a crucial role in the pathophysiology of hippocampal damage-induced memory impairment.
Fahaid H AL-Hashem   +6 more
doaj   +1 more source

Treatment with Brusatol inhibits oncogenic transcription factors NRF2 and TAZ, reducing glioma stem cells survival

open access: yes, 2018
Resumen del trabajo presentado al 5th Symposium on Biomedical Research: "Advances and Perspectives In Pharmacology, Drug Toxicity and Pharmacogenetics", celebrado en Madrid del 15 al 16 de marzo de 2018.Glioblastomas are nervous system solid tumours with
Pajares, Marta   +12 more
core   +1 more source

Identity of Brusatol and Yatansin, An Antidysentric Agent

open access: yesAgricultural and Biological Chemistry, 1980
SATO, Yukiharu   +2 more
openaire   +2 more sources

PB2168: BRUSATOL INDUCES APOPTOSIS IN AGGRESSIVE LYMPHOMA CELLS IN VITRO AND SYNERGIZES WITH VENETOCLAX

open access: yesHemaSphere, 2022
M. Szmyra   +9 more
doaj   +1 more source

The Nrf2/HO‐1 pathway participates in the antiapoptotic and anti‐inflammatory effects of platelet‐rich plasma in the treatment of osteoarthritis

open access: yesImmunity, Inflammation and Disease
Introduction We aimed to explore the molecular mechanisms through which platelet‐rich plasma (PRP) attenuates osteoarthritis (OA)‐induced pain, apoptosis, and inflammation.
Guangyu Du   +3 more
doaj   +1 more source

Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2

open access: yes, 2015
The transcription factor Nrf2 regulates the basal and inducible expression of a battery of cytoprotective genes. Whereas numerous Nrf2-inducing small molecules have been reported, very few chemical inhibitors of Nrf2 have been identified to date.
Wong, MW   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy